Shriram Finance Share Price Outlook: MUFG’s ₹39,618 Crore Stake Deal, Analyst Targets, and What to Watch Next (Dec 25, 2025)

Indian equity markets are shut on Thursday, December 25, 2025, for Christmas, but Shriram Finance Limited (NSE: SHRIRAMFIN) is still very much “open for discussion” after one of the biggest deal headlines of the year: Japan’s MUFG is set to buy 20% of Shriram Finance via a ₹39,618 crore preferential issue. ^[1]

With the stock closing around ₹973–₹974 on December 24 (the last trading day before the holiday) and printing a fresh 52-week high of ₹983.70, investors are now balancing two forces: the excitement of a global strategic partner and the near-term math of dilution. ^[2]

Below is the full news-and-forecast snapshot as of 25.12.2025, including the most cited catalysts, the freshest brokerage target changes, and the next concrete dates that could move the stock.

Shriram Finance stock: the Dec 25 snapshot (price, trend, and context)

Because the BSE and NSE are closed on December 25, the most recent price reference is Wednesday’s close. ET Now’s market-holiday bulletin confirms trading is suspended across segments today and resumes on Friday, December 26. ^[3]

As of the last session (Dec 24):

Last close: roughly ₹974 (reported around ₹974 on NSE/BSE data feeds) ^[4]
52-week high: ₹983.70 (set on Dec 24) ^[5]
52-week low: ₹493.35 (Jan 20, 2025) ^[6]

That says something simple but important: Shriram Finance has nearly doubled from its 52-week low to the current zone, a move that usually doesn’t happen on vibes alone—markets are pricing in a structural shift. ^[7]

The big catalyst: MUFG’s 20% stake purchase (and why it matters)

What’s been announced

The core headline is now widely reported: MUFG will acquire a 20% stake in Shriram Finance for about $4.4 billion (₹39,618 crore)—described by Reuters as the largest cross-border investment in India’s financial sector. ^[8]

Shriram Finance has also disclosed that MUFG will receive minority protection rights (including board representation and pre-emptive rights) that lapse if its stake drops below a specified threshold. ^[9]

The key “extra” detail investors are watching: the non-compete fee

Reuters also reported MUFG will pay a one-time $200 million non-compete and non-solicit fee to Shriram Ownership Trust, subject to shareholder approval—an element that tends to spark debate because it’s separate from the equity infusion into the operating company. ^[10]

Why markets care: capital, ratings, and funding costs

Broker commentary has been unusually consistent on the “why this matters” logic:

A bigger capital buffer can support faster loan growth without straining regulatory ratios.
A credible global financial institution on the cap table can strengthen the case for rating upgrades and lower borrowing costs, especially versus AAA-rated peers.

Financial Express notes that analysts see a funding benefit because Shriram Finance has been borrowing at a premium to AAA peers, and the MUFG association could accelerate a path toward a stronger rating profile. ^[11]

“Will Shriram Finance become a bank?” Management’s answer is (currently) no

A sharp rumor-and-reality loop kicked off after public commentary by Uday Kotak raised the question of whether Shriram Finance could eventually apply for a banking licence.

Shriram Finance management has responded clearly in public:

Moneycontrol reported that Umesh Revankar (Executive Vice Chairman) said a banking licence is not under discussion, and the company prefers to remain an NBFC for now, emphasizing flexibility and room to expand in retail lending without changing its structure. ^[12]
Livemint similarly reported Shriram Finance ruled out plans to apply for a banking licence following the MUFG investment. ^[13]

This matters for the stock because “bank optionality” can inflate expectations fast. For now, the company’s public stance is: focus on the existing model, not a regulatory transformation. ^[14]

Upcoming shareholder vote: EGM date is now out

One near-term event is no longer speculative: the shareholder meeting.

Business Standard’s filings feed carries the notice language that an Extra-Ordinary General Meeting (EGM) will be held on Wednesday, January 14, 2026 at 11:00 a.m. IST, via VC/OAVM. ^[15]

In practical terms, this is the next hard checkpoint for:

the preferential allotment mechanics,
any special rights framework,
and deal-linked approvals that require shareholder sign-off.

Analyst targets and forecasts: what brokerages are saying (as of Dec 25)

If you’re looking for the “market’s current forward map,” this is it: brokers have been raising targets and tweaking growth and funding assumptions after the MUFG deal, while acknowledging near-term dilution.

Higher targets: the numbers most frequently cited right now

A sampling of the most visible published targets over the last few days:

ICICI Securities: Target ₹1,225, maintaining a Buy; highlights governance strengthening (including MUFG nominee directors) and upgrades book value assumptions post-transaction. ^[16]
Motilal Oswal: Target ₹1,100, Buy; projects strong profitability trajectory over the coming years and argues the deal is strategically value-accretive, with rating-upgrade potential. ^[17]
Prabhudas Lilladher: Target ₹1,060, Buy; explicitly frames the infusion as strengthening capital and resilience, with a path toward a rating upgrade. ^[18]
Nomura (as reported by Financial Express): Target raised to ₹1,140 and expects AUM growth could rise toward ~20% medium term after the infusion, narrowing the gap with faster-growing peers. ^[19]
Citi (via Economic Times): maintained Buy and raised the target to ₹1,100 from ₹870, citing balance-sheet strengthening and meaningful capital ratio improvements after the deal. ^[20]

Business Standard also summarized a cluster of upgrades—citing targets around ₹1,050–₹1,140 across multiple brokerages after the deal announcement. ^[21]

What changed inside the models (the “why” behind upgrades)

Analysts are broadly pointing to three model levers:

Higher growth runway
Nomura’s view (reported by Financial Express) is that the enlarged capital base can “materially alter” Shriram Finance’s growth trajectory, with medium-term AUM growth potentially rising to ~20%. ^[22]
Lower cost of funds over time
Brokerages repeatedly frame MUFG’s entry as a catalyst for a faster rating upgrade path and a narrowing funding-cost gap versus AAA peers. ^[23]
Near-term RoE dilution, longer-term valuation reset
Several reports explicitly note that return on equity may look softer in the near term because the equity base expands materially—but argue the trade-off is a stronger franchise with better funding economics. ^[24]

Today’s (Dec 25) market commentary: profit-booking levels and technical zones

Since you asked specifically for 25.12.2025 commentary: ET Now published a same-day piece citing Motilal Oswal Financial Services’ research commentary suggesting booking partial profit around ₹1,000 after explaining the stock’s sharp run post-deal. ^[25]

The same article also quoted another market analyst calling ₹880–₹900 an attractive accumulation zone on dips (rather than chasing strength), with higher upside targets discussed for positional trades. ^[26]

Important context: these are short-horizon trading opinions, not company guidance, and they tend to change quickly when markets reopen. ^[27]

Fundamentals check: what Shriram Finance looks like underneath the headline

A deal can re-rate a stock, but it can’t repeal credit cycles. So what’s the base business?

Indian Express reported that as of end-September, Shriram Finance had:

about 97 lakh customers,
AUM of ₹2.81 lakh crore, and
a loan mix led by commercial vehicle loans (46%), followed by passenger vehicle loans (21%) and MSME loans (14%). ^[28]

On recent earnings momentum, Reuters reported the company delivered a bigger-than-expected profit for the quarter ended September 30, 2025, supported by lending growth in MSME and commercial vehicle segments. ^[29]

This matters because the MUFG partnership thesis leans on a simple idea: Shriram Finance already has a large, diversified retail-credit engine; the deal is meant to fund a faster, cheaper, more resilient version of that engine, not invent a new one. ^[30]

The main risks investors are weighing (and why they’re real)

Even bullish analysts keep circling a few non-negotiable watchpoints:

1) Execution and approvals risk

The transaction is still subject to shareholder and regulatory approvals. ^[31]

2) Dilution vs. growth pay-off

A preferential issue adds shares—so if growth and funding benefits don’t show up on schedule, RoE optics can disappoint even while absolute profit grows. ^[32]

3) Credit cycle risk (especially in asset-backed lending)

Shriram’s strength—deep exposure to vehicle finance and underbanked segments—is also where macro stress can surface first if freight cycles, used-vehicle prices, or borrower cash flows weaken. (This is structural to the business model; it’s why funding cost and underwriting discipline matter so much.) ^[33]

4) “Strategic partner” expectations management

Markets can get overeager and price in outcomes like instant AAA ratings, rapid margin expansion, or major business-model shifts. Management’s messaging so far is more conservative: no bank licence push, no abrupt operating-model rewrite. ^[34]

What to watch next (the dates that matter)

Here are the next catalysts that are actually on the calendar:

Markets reopen: Friday, December 26, 2025 (post-Christmas holiday). ^[35]
Shareholder meeting: EGM on January 14, 2026 (11:00 a.m. IST, VC/OAVM). ^[36]
Ongoing brokerage revisions: target prices and rating theses are still updating rapidly post-deal (as seen across Nomura, ICICI Securities, Motilal Oswal, and others). ^[37]

Bottom line (as of Dec 25, 2025)

As of 25.12.2025, the Shriram Finance stock narrative is being dominated by one theme: MUFG’s entry is widely interpreted as a balance-sheet and funding-profile upgrade—the kind of event that can change a lender’s growth ceiling and valuation framework. ^[38]

But the stock is also coming into this phase after a strong run and near its 52-week highs, meaning the market will demand follow-through: clean approvals, clear deal timelines, and evidence that capital strength turns into sustainable, well-priced growth, not just a bigger equity base. ^[39]

References